Corporate Investor

Updated:

Betta Pharmaceuticals

Betta Pharmaceuticals was founded in 2003. It functions as a corporate investor headquartered in Hangzhou, China. The firm concentrates on pharmaceutical...

Betta Pharmaceuticals logo

Betta Pharmaceuticals

Betta Pharmaceuticals was founded in 2003. It functions as a corporate investor headquartered in Hangzhou, China. The firm concentrates on pharmaceutical development and marketing. Its work covers malignant tumors, ophthalmology, autoimmune diseases and diabetes. Operations remain centered in China with no disclosed positions in other regions or named portfolio companies. No team size, additional offices or adjacent vehicles appear in available records. No operational events from the last 24 months are documented. The firm maintains a corporate structure tied directly to its pharmaceutical operations rather than external fund vehicles or co-investment clubs.

General information

Firm type

Corporate Investor

Year founded

2003

AUM

Undisclosed

Location

Region

Asia

Country

China

City

Hangzhou

Corporate office

Hangzhou, China

Sector focus

Healthcare Services

Frequently asked questions

Who runs investment decisions at Betta Pharmaceuticals?

No named principals or investment committee members are disclosed in available records.

Does Betta Pharmaceuticals participate in fund commitments or only direct deals?

Available information shows no fund commitments or direct deal activity beyond internal pharmaceutical development.

What investment stages does Betta Pharmaceuticals typically target?

No stage preferences or external investment stages are documented.

Where does the underlying wealth come from?

Wealth origin is not separately disclosed beyond the firm's own pharmaceutical operations.

How is Betta Pharmaceuticals related to any parent or spinout?

No parent company, spinout or related vehicle is identified in the source material.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Hangzhou Corporate Investor profiles